Publications

Linezolid Experience and Accurate Determination of Resistance (LEADER) Program 2007: Assessing Oxazolidinone and Inducible Clindamycin Resistance, Lead author: Ross JE, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Antimicrobial Activity of Doripenem Against Leading Bacterial Pathogens: Results from a Latin American Surveillance Study (2003-2006), Lead author: Gales AC, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Regression Analysis of MIC Versus Disk Diffusion Zone Diameters for Three Carbapenems Tested against Enterobacteriaceae Isolates Harboring Serine Carbapenemases with Matched Control Strains, Lead author: Fritsche TR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Proposed Susceptibility Testing Criteria for H. influenzae Tested Against Piperacillin/Tazobactam: Report Using Results from the SENTRY Program and Japan Surveillance Isolates, Lead author: Jones RN, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Critical evaluations of generic piperacillin/tazobactam compared to the branded product: a worldwide sampling of 26 intravenous formulations, Lead author: Moet G, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Increased antimicrobial susceptibility profiles among polymyxin-B-resistant Acinetobacter baumannii clinical isolates, Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Analyses supporting phase 2 clinical trial dose selection for zabofloxacin in community-acquired pneumonia, Lead author: Ambrose PG, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Characterisation of baseline methicillin-resistant Staphylococcus aureus isolates from a phase IV clinical trial of complicated skin and soft tissue infections, Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Occurrence of carbapenemase-producing Enterobacteriaceae clinical isolates in the Asia-Pacific nations, Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Acquired carbapenemase-encoding genes among Gram-negative isolates in USA medical centres: report from the MYSTIC Program (2007), Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Daptomycin activity and spectrum when tested against Gram-positive species responsible for bloodstream infections in European medical centres, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Activity of tigecycline tested against vancomycin-resistant enterococci, including clonal complex-17 E. faecium strains, isolated in Europe, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

A Global Evaluation of Voriconazole Activity Against Recent Clinical Isolates of Candida spp., Lead author: Diekema DJ, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Antimicrobial activity of telavancin against Enterococcus faecalis, E. faecium and E. avium: results from a European surveillance program (2007), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Activity of telavancin tested against viridans group and beta-haemolytic streptococci, and multidrug-resistant Streptococcus pneumoniae, Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Antimicrobial activity of telavancin and comparator agents tested against recently isolated (2007) European Staphylococcus aureus and coagulase-negative staphylococci, Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Dalbavancin (DECIDE) tested against indicated Gram-positive species in European medical centres: results from France, Lead author: Leclercq, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Comparative activity of dalbavancin tested against indicated Gram-positive species in Europe: results from two Spanish medical centres (DECIDE Program), Lead author: Canton R, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Definition of wildtype MIC distributions for targeted species for determination of optimal dosing for zabofloxacin, a novel fluoronaphthyridone, Lead author: Jones RN, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Antimicrobial activity of ceftobiprole tested against leading European bacterial pathogens: results from an international surveillance programme (2005-2006), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Enhanced activity of daptomycin and vancomycin combined with imipenem or oxacillin against community-acquired MRSA isolates, Lead author: Jones RN, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Rapid emergence and dissemination of bla_CTX-M among Enterobacteriaceae in USA medical centres: report from the MYSTIC Program (2007), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Resistance surveillance of bacterial pathogens from North American patients hospitalised with pneumonia: a 10-year report from the SENTRY Program (1997-2006), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Escalating resistance among non-fermentative Gram-negative bacilli: Report from the North American SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Trends in prevalence and antimicrobial susceptibilities among skin and skin structure infection pathogens in North America: Report from the SENTRY Program (1997-2005), Lead author: Moet G, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Acinetobacter spp. infections: the Latin American scenario in the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Potency and spectrum of tigecycline tested against bacterial pathogens producing skin and skin structure infections in European medical centres, including community-acquired methicillin-resistant S. aureus, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

In vitro activity of tigecycline tested against pneumonia pathogens from patients hospitalised in European medical centres, including multidrug-resistant Acinetobacter spp., Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Tigecycline activity tested against bacterial isolates causing bloodstream infections in European medical centres, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Analysis of resistance and vancomycin &quotreverse creep&quot in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Picao, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Frequency and antimicrobial susceptibility profile of vancomycin-resistant enterococci from Latin America: a report from the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Prevalence of vancomycin-resistant Enterococcus spp. and associated resistance patterns among isolates collected over a decade of SENTRY Program surveillance in North America, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Genetic characterisation of the new blaVIM-18 and comparative antimicrobial susceptibility profile of VIM-18 with highest homologous VIM-variant, VIM-2: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

High carbapenem resistance among Pseudomonas aeruginosa from India: a national epidemic of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

bla_VIM-2-carrying integron among Enterobacteriaceae isolates in Mexico: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Wide variation in rates of ESBL production among Escherichia coli causing bacteraemia in the Asia-Pacific region: A SENTRY Program Report, Lead author: Bell JM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Occurrence and resistance in pathogens from hospitalised patients with pneumonia in the Asia-Pacific region: a SENTRY Program Report (2006), Lead author: Bell JM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Preliminary Microbiology Results from a Phase III Omiganan Pentahydrochloride Clinical Trial: In Vitro Activity Against Bacterial and Fungal Pathogens, Lead author: Fritsche TR, presented at 18th annual Society for Healthcare Epidemiology of America, April 5 – 8, 2008, Orlando, FL

Daptomycin Activity Tested Against Gram-Positive Cocci Isolated in Canadian Medical Centers (2004-2007), Lead author: Roscoe D, presented at 2008 Canada AMMI Conference, February 27 – March 2, 2008, Vancouver, Canada

Antimicrobial Activity and Spectrum of Daptomycin and Comparator Agents Tested Against Gram-Positive Organisms Collected from Patients with Cancer, Lead author: Sader HS, presented at MD Anderson Second Infections in Cancer Symposium, February 21-23, 2008, Houston, TX

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: Results from the SENTRY Antimicrobial Surveillance Program (2005-2006). by Fritsche TR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 86-95

Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. by Biedenbach DJ, Jones RN and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2008; 61 (2): 240-244

Comparative activity of meropenem in US medical centers (2007): Initiating the 2nd decade of MYSTIC Program surveillance. by Jones RN, Kirby JT and Rhomberg PR published in Diagn. Microbiol. Infect. Dis. 2008; 61 (2):203-213

Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. by Fritsche TR, Rhomberg PR, Sader HS and Jones RN published in J. Antimicrob. Chemother. 2008; 61 (5): 1092-1098

In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate and -resistant Staphylococcus aureus. by Fritsche TR, Rhomberg PR, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2008; 60 (4): 399-403

Antimicrobial activities of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program. by Castanheira M, Sader HS, Deshpande LM, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2008; 52 (2): 570-573

Novel ß-lactams. by Gales AC and Sader HS published in Braz. J. Infect. Dis. 2008; 12 (Suppl. 2): S46-S58

Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. by Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J and Drusano GL published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 13-20

Update of the in vitro activity of daptomycin tested against 6,710 Gram-positive cocci isolated in North America (2006). by Castanheira M, Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2008; 61 (2): 235-239

IMP-producing Pseudomonas aeruginosa strain isolated in a US medical center: A recent arrival from Mexico. by Martin CA, Morita K, Ribes JA, Deshpande LM, Sader HS and Castanheira M published in Antimicrob. Agents Chemother. 2008; 52 (6): 2289-2290